SBDM-011

N/A

Report date: 2024/08/21 14:09:26

Base Information

Drug NameSBDM-011
Drug Alias NameSBDM-011
ClassificationBiologics > Biosimilar
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShilpa Biologicals Pvt Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A